PUBLIKATIONEN
- Publikationen 2010
- Publikationen 2009
- Publikationen 2008
- Publikationen 2007
- Publikationen 2006
- Publikationen 2005
- Publikationen 2004
Publikationen 2011 sortiert nach der Höhe des Impact-Faktors 2010
| IF | Publikationen: Autoren - Titel - Zeitschrift |
| 30 | Galmiche J-P, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Langstrom G, Lind T, Lundell L, Hölscher AH, group L-S. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 2011;305:1969-1975. |
| 7,5 | Hölscher AH, Bollschweiler E. Early gastric cancer with lymph node metastasis. Ann Surg 2011; 253(4):840-1. |
| 7,5 | Hölscher AH, Bollschweiler E, Schröder W, Metzger R, Gutschow C, Drebber U. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg 2011, Nov;254(5):802-8. |
| 7,5 | Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Holscher AH. Comparison Between Endoscopic and Surgical Resection of Mucosal Esophageal Adenocarcinoma in Barrett's Esophagus At Two High-Volume Centers. Ann Surg 2011;254:67-72. |
| 7,3 | Grimminger PP, Danenberg P, Dellas K, Arnold D, Rodel C, Machiels JP, Haustermans K, Debucquoy A, Velenik V, Sempoux C, Bracko M, Holscher AH, Semrau R, Yang D, Danenberg K, Lenz HJ, Vallbohmer D. Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer. Clin Cancer Res 2011;17:3469-3477. |
| 7,3 | Hu-Lieskovan S, Vallbohmer D, Zhang W, Yang D, Pohl A, Labonte MJ, Grimminger PP, Hoelscher AH, Semrau R, et al. EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients. Clinical Cancer Research 2011;17:5161-5169. |
| 5,6 | Bollschweiler E, Holscher AH. Early adenocarcinoma of the esophagus - clinical relevance of depth of infiltration into the submucosa. Clin Gastroenterol Hepatol 2011; 9(3):277. |
| 3,9 | Narumiya K, Metzger R, Bollschweiler E, Alakus H, Brabender J, Drebber U, Holscher AH, Warnecke-Eberz U. Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer. Pharmacogenomics 2011;12:205-14. |
| 3,9 | Schmidt MC, Kahraman B, Neumair D, Ortmann M, Stippel DL. Tc-99m-MIBI-Negative Parathyroid Adenoma in Primary Hyperparathyroidism Detected by C-11-Methionine PET/CT After Previous Thyroid Surgery. Cln Nucl Medicine 2011 Dec;36(12):1153-5. |
| 3,8 | Twarock S, Freudenberger T, Poscher E, Dai G, Jannasch K, Dullin C, Alves F, Prenzel K, Knoefel WT, Stoecklein NH, Savani RC, Homey B, Fischer JW. Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis. Molecular Cancer 2011;10. |
| 3,6 | Bollschweiler E, Hölscher AH, Metzger R, Besch S, Mönig SP, Baldus SE, Drebber U. Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer. Ann Thorac Surg 2011;92:2020-7. |
| 3,6 | Eich H, Stepien A, Zimmermann C, Hellmich M, Metzger R, Holscher A, Muller R. Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression. Strahlenther Onkol 2011;187:225-30. |
| 3,2 | Wahba R, Teschner S, Stippel DL. Results of kidney transplantation after rescue allocation. Transplant International 2011;24:e46-e47. |
| 2,6 | Drebber U, Madeja M, Odenthal M, Wedemeyer I, Monig SP, Brabender J, Bollschweiler E, Holscher AH, Schneider PM, Dienes HP, Vallbohmer D. beta-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis. Int J Colorec Dis 2011;26:1127-34. |
| 2,6 | Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, Brabender J, Mönig S, Hölscher AH, Dienes HP, Odenthal M. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int J Oncol 2011;39:409-15. |
| 2,6 | Schneider PM, Vallbohmer D, Ploenes Y, Lurje G, Metzger R, Ling F, Brabender J, Drebber U, Hölscher AH Evaluation of quality indicators following implementation of total mesorectal excision in primarily resected rectal cancer changed future management. Int J Colorectal Dis 2011;26:903-9. |
| 2,2 | Fetzner UK, Holscher AH, Stippel DL. Regional lymphadenectomy strongly recommended in T1b gallbladder cancer. World J Gastroenterol 2011;17:4347-8. |
| 1,9 | Jaworski R, Bollschweiler E, Holscher AH, Monig SP, Skokowski J, Zielinski J, Swierblewski M, Kopacz A, Jaskiewicz J. Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany. Gastric cancer 2011;14:234-41. |
| 1,1 | Moehler M, Al-Batran...Hölscher AH, ...Mönig S. .. German S3-guideline "Diagnosis and treatment of esophagogastric cancer. Z Gastroenterol 2011;49:461-531. |
| 1,0 | Wahba R, Kleinert R, Prenzel K, Bangard C, Holscher AH, Stippel DL. Laparoscopic deroofing of nonparasitic liver cysts with or without greater omentum flap. Surg Laparosc Endosc Percutan Tech 2011;21:54-8. |
| 0,8 | Gutschow CA, Schroder W, Bludau M, Vallbohmer D, Prenzel KL, Bollschweiler E, Holscher AH. Value of Distal Gastrectomy as a Remedial Operation for Failed Fundoplication. Zentralbl Chir 2011;136:249-255. |
| 0,8 | Holscher AH, Fetzner UK, Bludau M, Leers J. Complications and Management of Complications in Oesophageal Surgery. Zentralbl Chir 2011;136:213-223. |
| 0,8 | Vallbohmer D, Schroder W, Brabender J, Holscher AH. Oesophageal cancer: current status of multimodality therapy. Zentralblatt fur Chirurgie 2011;136:312-6. |
| 0,5 | Vallbohmer D, Hölscher A. Positron emission tomography in tumors of the upper gastrointestinal tract: controversial value. Dtsch Med Wochenschr 2011;136:1060. |
| 0,1 | Vallbohmer D, Schroder W, Brabender J, Holscher AH. Therapy of Barrett's Adenocarcinoma. Viszeralmedizin 2011;27:157-161. |
| - | Gutschow CA, Leers JM, Schroder W, Prenzel KL, Fuchs H, Bollschweiler E, Bludau M, Holscher AH. Effect of aging on esophageal motility in patients with and without GERD. German medical science : GMS e-journal 2011;9:Doc22. |
Publikationen 2010 sortiert nach der Höhe des Impact-Faktors 2009
| IF | Publikationen: Autoren - Titel - Zeitschrift |
| 17.8 | Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, ...., Hoelscher A, Schneider PM, .... , Siewert JR, Schlag PM. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European organisation for research and treatment of cancer randomized trial 40954. J Clin Oncol 2010;28:5210-8. |
| 7.9 | Schmidt M, Bollschweiler E, Hölscher AH F-18-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer. Ann Surg 2010; 252: 412-413 |
| 7.9 | Lurje G, Leers JM, Pohl A, Oezcelik A, Zhang W, Ayazi S, Winder T, Ning Y, Yang DY, Klipfel NE, Chandrasoma P, Hagen JA, DeMeester SR, DeMeester TR, Lenz HJ. Genetic Variations in Angiogenesis Pathway Genes Predict Tumor Recurrence in Localized Adenocarcinoma of the Esophagus. Annals of Surgery2010,;251:857-864. |
| 7.9 | Vallbohmer D, Holscher AH, DeMeester S, DeMeester T, Salo J, Peters J, Lerut T, Swisher SG, Schroder W, Bollschweiler E, Hofstetter W. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg 2010;252:744-9. |
| 6,7 | Jun Y, Bulk E, Ji P,Hascher A,Tang M, Metzger R, Marra A, Serve H, Berdel WE, Wiewroth R, Koschmieder S, Carsten Müller-Tidow The EPHB6 Receptor Tyrosine Kinase Is a Metastasis Suppressor That Is Frequently Silenced by Promoter DNA Hypermethylation in Non–Small Cell Lung Cancer Clin Cancer Res April 15, 2010 16:2275-2283 |
| 6,0 | Fiocca R, Mastracci L, ...Hölscher AH, et al. Long-Term Outcome of Microscopic Esophagitis in Chronic GERD Patients Treated With Esomeprazole or Laparoscopic Antireflux Surgery in the LOTUS Trial. American Journal of Gastroenterology 2010;105. |
| 5,5 | C. Gutschow, A.H. Hölscher Myotomy for esophageal achalasia - laparoscopic versus peroral endoscopic approach. Endoscopy 2010,245:265-271 |
| 5,4 | Alakus H, Holscher AH, Grass G, Hartmann E, Schulte C, Drebber U, Baldus SE, Bollschweiler E, Metzger R, Monig SP. Extracapsular lymph node spread: a new prognostic factor in gastric cancer. Cancer 2010;116:309-315. |
| 4,1 | Bollschweiler E, Besch S, Drebber U, Schroder W, Monig SP, Vallbohmer D, Baldus SE, Metzger R, Holscher AH. ^ Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer. Ann Surg Oncol 2010;17:3187-94. |
| 3,9 | Metzger R, Heukamp L, Drebber U, Bollschweiler E, Zander T, Hoelscher AH, Warnecke-Eberz U. CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer. Pharmacogenomics 2010;11:1105-13. |
| 3,9 | Warnecke-Eberz U, Metzger R, Bollschweiler E, Baldus SE, Mueller RP, Dienes HP, Hoelscher AH, Schneider PM. TaqMan low-density arrays and analysis by artificial neuronal networks predict response to neoadjuvant chemoradiation in esophageal cancer. Pharmacogenomics 2010;11:55-64. |
| 3,9 | Hoffmann AC, Vallbohmer D, Grimminger P, Metzger R, Prenzel KL, Hoelscher AH, Brabender J. Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma. Pharmacogenomics 2010;11:341-7. |
| 3,6 | Bludau M, Holscher AH, Vallbohmer D, Gutschow C, Schroder W. Ischemic conditioning of the gastric conduit prior to esophagectomy improves mucosal oxygen saturation. Ann Thorac Surg 2010;90:1121-6. |
| 3,6 | Prenzel KL, Bollschweiler E, Schroder W, Monig SP, Drebber U, Vallboehmer D, Holscher AH. Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg 2010;90:1662-7. |
| 3,6 | Bangard C, Rosgen S, Wahba R, Wiemker R, Hellmich M, Reiter H, Fischer JH, Stippel DL, Lackner KJ. Large-volume multi-tined expandable RF ablation in pig livers: comparison of 2D and volumetric measurements of the ablation zone. Eur Radiol 2010;20:1073-8. |
| 3,1 | Grimminger PP, Schneider PM, Metzger R, Vallbohmer D, Danenberg KD, Danenberg PV, Holscher AH, Brabender J. The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC). Lung Cancer 2010;70:82-7. |
| 2,7 | Alakus H, Afriani N, Warnecke-Eberz U, Bollschweiler E, Fetzner U, Drebber U, Metzger R, Holscher AH, Monig SP. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. World J Surg 2010;34:2853-9. |
| 2,7 | Ling FC, Vallbohmer D, Hoelscher AH, Schmidt D, Bollschweiler E, Schneider PM. Increased platelet counts after transthoracic en bloc resection for esophageal cancer is associated with significantly improved survival. World J Surg 2010;34(11):2628-34. |
| 2,7 | Schröder W, Hölscher AH, Bludau M, Vallbohmer D, Bollschweiler E, Gutschow C. Ivor-lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg 2010;34:738-43. |
| 2,7 | Fetzner UK, Prenzel KL, Alakus H, Holscher AH, StippelD Precise Preoperative Imaging and Adequate Oncologic Resection is Most Important in Achieving Long-Term Prognosis in Gallbladder Cancer. World J Surg 2010;34:2262-2263. |
| 2,5 | Vallbohmer D, Holscher AH, Schneider PM, Schmidt M, Dietlein M, Bollschweiler E, Baldus S, Alakus H, Brabender J, Metzger R, Monig SP. (18)F -fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. J Surg Oncol 2010;102:135-40. |
| 2,4 | Vallbohmer D, Brabender J, Metzger R, Holscher AH. Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors. J Gastrointest Surg;14 Suppl 1:S75-80. |
| 2,2 | Grimminger PP, Brabender J, Warnecke-Eberz U, Narumiya K, Wandhofer C, Drebber U, Bollschweiler E, Holscher AH, Metzger R, Vallbohmer D. XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer. J Surg Res 2010;164:e61-6. |
| 2,1 | Metzger R, Bollschweiler E, Drebber U, Monig SP, Schroder W, Alakus H, Kocher M, Baldus SE, Holscher AH. Neoadjuvant chemoradiotherapy for esophageal cancer: impact on extracapsular lymph node involvement. World J Gastroenterol 2010;16:1986-92. |
| 2,0 | Libicher M, Herbrik M, Stippel D, Poggenborg J, Bovenschulte H, Schwabe H. Portal Vein Embolization using the Amplatzer Vascular Plug II: Preliminary Results. Rofo 2010;182:501-506. |
| 1,6 | Gutschow CA, Tox U, Leers J, Schafer H, Prenzel KL, Holscher AH. Botox, dilation, or myotomy? Clinical outcome of interventional and surgical therapies for achalasia. Langenbecks Arch Surg 2010;395:1093-9. |
| 1,6 | Holscher AH. Keiichi Maruyama MD, professor of surgery, Tokyo. Langenbecks Arch Surg 2010;395:987-8. |
| 1,5 | Grimminger PP, Schneider PM, Metzger R, Vallbohmer D, Danenberg KD, Danenberg PV, Holscher AH, Brabender J. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer. Clin Lung Cancer;11:114-9. |
| 1,5 | Grimminger PP, Schneider PM, Metzger R, Vallbohmer D, Holscher AH, Danenberg PV, Brabender J. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer. Clin Lung Cancer 2010;11:328-34. |
| 1,5 | Vallbohmer D, Hölscher AH, Hölscher M, Bludau M, Gutschow C, Stippel D, Bollschweiler E, Schröder W. Options in the management of esophageal perforation: analysis over a 12-year period. Diseases of the Esophagus 2010;23:185-190. |
| 1,4 | Fetzner UK, Oana IC, Buschel P, Kasch R, Alakus H, Moenig SP, Herbold T, Stippel DL, Scheele J. Phytobezoar: impact of differential diagnosis and difficulties in technical diagnostics. Comment on: Park JW, Chae HD: phytobezoar of the stomach. Dig Surg 2010;27:339. |
| 1,3 | Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallbohmer D, Prenzel KL, Metzger R, Bollschweiler E, Holscher AH, Monig SP. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Nucl Med Commun 2010;31:532-8. |
| 1,5 | Kasper HU, Bangard C, Gossmann A, Dienes HP, Stippel DL: Pathomorphological changes after radiofrequency ablation in the liver. Pathol Int 60, 149 (2010) |
| 1,4 | Retterspitz MF, Monig SP, Schreckenberg S, Schneider PM, Holscher AH, Dienes HP, Baldus SE. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis. Anticancer Res 2010;30:4635-41. |
| 1,4 | Kasper H-U, Konze E, Dienes HP, Stippel DL, Schirmacher P, Kern M. COX-2 Expression and Effects of COX-2 Inhibition in Colorectal Carcinomas and their Liver Metastases. Anticancer Res 2010;30:2017-23. |
| 1,2 | Kasper HU, Konze E, Kern M, Stippel DL. CD95 and TNFalpha-induced apoptosis in liver metastases of colorectal carcinoma. In Vivo 2010;24:653-7. |
| 0,6 | Saeger HD, Kersting S, Vogelbach P, Hamel C, Oertli D, Holscher A, Thomas WEG. Course system of the Working Group for Gastro-intestinal Surgery Davos. Chirurg;81:25-30. |
| 0,6 | Schröder W, Welcker K. Finanzierung der chirurgischen Weiterbildung Chirurg 2010; 81:31-37 |
| 0 | Bollschweiler E, Holscher AH, Metzger R. Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer. Future Oncol 2010;6:25-35. |
| 0 | Metzger R, Bollschweiler E, Holscher AH, Warnecke-Eberz U. ERCC1: impact in multimodality treatment of upper gastrointestinal cancer. Future Oncol 2010;6:1735-49. |
| 0 | Mönig SP, Holscher AH. Clinical classification systems of adenocarcinoma of the esophagogastric junction. Recent Results Cancer Res 2010;182:19-28. |
| 0 | Kleinert R, Wahba R, Bangard C, Prenzel K, Holscher AH, Stippel D. Radiomorphology of the Habib sealer-induced resection plane during long-time followup: a longitudinal single center experience after 64 radiofrequency-assisted liver resections. HPB Surg 2010;2010:403097. |
| 0 | Prenzel KL, Holscher AH, Vallbohmer D, Drebber U, Gutschow CA, Monig SP, Stippel DL. Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head. Eur J Surg Oncol 2010;36:993-996. |
| 0 | Stippel, D.L.: Radiofrequenzablation von Lebermetastasen. Chirurgie im Blick 1, 8 |
| 0 | Fetzner UK, Oana IC, Stippel DL. Extrahepatic bile duct resection in gallbladder carcinoma: differentiated discussion about risk and oncological benefit. Saudi J Gastroenterol 2010;16:307-8. |
Publikationen 2009 sortiert nach der Höhe des Impact-Faktors 2008
| IF | IF Publikationen: Autoren - Titel - Zeitschrift |
| 8,5 | Bollschweiler E, Hölscher AH, Obliers R. Improving informed consent of surgical patients using a multimedia-based program?: results of a prospective randomized multicenter study of patients before cholecystectomy. Ann Surg 2009; 249(3):547-8. |
| 8,5 |
Hölscher AH, Drebber U, Schulte C, Mönig SP, Vallböhmer D, Bollschweiler E. |
| 8,5 | Hölscher AH, Vallböhmer D, Bollschweiler E. Closing the loop around esophagectomy after neoadjuvant therapy. Ann Surg 2009; 250(3):580. |
| 8,5 | Vallbohmer D, Holscher AH, Dietlein M, Bollschweiler E, Baldus SE, Monig SP, Metzger R, Schicha H, Schmidt M. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 2009;250:888-94. |
| 6,1 | Ayazi S, Lipham JC, Portale G, Peyre CG, Streets CG, Leers JM, Demeester SR, Banki F, Chan LS, Hagen JA, Demeester TR. Bravo Catheter-Free pH Monitoring: Normal Values, Concordance, Optimal Diagnostic Thresholds, and Accuracy. Clin Gastroenter Hepatol 2009;7:60-67. |
| 5,4 | Alakus H, Warnecke-Eberz U, Bollschweiler E, Monig S, Vallbohmer D, Brabender J, Drebber U, Baldus S, Riemann K, Siffert W, Holscher A, Metzger R. GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Pharmacogenomics J 2009;9:202-207. |
| 5,0 | Loeffler-Ragg J, Mueller D, Gamerith G, Auer T, Skvortsov S, Sarg B, Skvortsova I, Schmitz K, Martin H, Krugmann J, Alakus H, Maser E, Menzel J, Hilbe W, Lindner H, Schmid K, Zwierzina H. Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib. Mol Cancer Ther 2009;8:1995-2006. |
| 4,9 | Bollschweiler E, Metzger R, Drebber U, Baldus S, Vallbohmer D, Kocher M, Hölscher A. Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol 2009;20:231-238. |
| 4,5 | Schmidt M, Bollschweiler E, Dietlein M, Mönig SP, Kobe C, Vallböhmer D, Eschner W, Hölscher AH, Schicha H. Mean and maximum standardized uptake values in FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy. Eur J Nucl Med Mol Imaging 2009; 36: 735-.744. |
| 3,9 | Brabender J, Arbab D, Huan X, Vallbohmer D, Grimminger P, Ling F, Neiss S, Bollschweiler E, Schneider PM, Holscher AH, Metzger R. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer. Ann Surg Oncol 2009;16:1378-83. |
| 3,9 | Metzger R, Drebber U, Baldus S, Mönig S, Hölscher A, Bollschweiler E. Extracapsular Lymph Node Involvement Differs Between Squamous Cell and Adenocarcinoma of the Esophagus Ann Surg Oncol 2009;16:447-453. |
| 3,9 | Koenig A, Prenzel K, Bogoevski D, Yekebas E, Bubenheim M, Faithova L, Vashist Y, Gawad K, Baldus S, Pantel K, Schneider P, Holscher A, Izbicki J. Strong Impact of Micrometastatic Tumor Cell Load in Patients with Esophageal Carcinoma Ann Surg Oncol 2009; 16: 454-462. |
| 3,7 | Oezcelik A, Banki F, DeMeester SR, Leers JM, Ayazi S, Abate E, Hagen JA, Lipham JC, DeMeester TR. Delayed esophagogastrostomy: a safe strategy for management of patients with ischemic gastric conduit at time of esophagectomy. J Am Coll Surg 2009;208:1030-4. |
| 3,2 | Ayazi S, Leers JM, Oezcelik A, Abate E, Peyre CG, Hagen JA, DeMeester SR, Banki F, Lipham JC, DeMeester TR, Crookes PF. Measurement of gastric pH in ambulatory esophageal pH monitoring. Surg Endoscopy 2009;23:1968-1973. |
| 3,2 | Leers JM, Vivaldi C, Schafer H, Bludau M, Brabender J, Lurje G, Herbold T, Holscher AH, Metzger R. Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent. Surg Endoscopy 2009;23:2258-2262. |
| 3,1 | Kuramochi H, Uchida K, Peters JH, Shimizu D, Vallbohmer D, Schneider S, Danenberg KD, Danenberg Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences. BMC Cancer 2009; May 21;9:157. |
| 3,0 | Leers JM, DeMeester SR, Chan N, Ayazi S, Oezcelik A, Abate E, Banki F, Lipham JC, Hagen JA, DeMeester TR. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovascul Surg 2009;138:594-602. |
| 2,6 | Bollschweiler E, Schloesser T, Leers J, Vallbohmer D, Schafer H, Hölscher AH. High prevalence of colonic polyps in white males with esophageal adenocarcinoma Dis Col Rectum 2009; 52: 299-304. |
| 2,5 | Hoffmann A-C, Brabender J, Metzger R, Ling F, Warnecke-Eberz U, Lurje G, Hoelscher AH, Schneider PM, Vallbohmer D. Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection. J Surg Oncol 2009;99:296-301. |
| 2,5 | Hoffmann AC, Kaifi JT, Vallbohmer D, Yekebas E, Grimminger P, Leers JM, Izbicki JR, Holscher AH, Schneider PM, Metzger R, Brabender J. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer. J Surg Oncol 2009;100:414-7. |
| 2,5 | Vallböhmer D, Drebber U, Schneider P, Baldus S, Bollschweiler E, Brabender J, Warnecke-Eberz U, Monig S, Hölscher A, Metzger R. Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. J Surg Oncol 2009 Apr 3;99(7):409-413 |
| 2,3 | Oezcelik A, Hagen JA, Halls JM, Leers JM, Abate E, Ayazi S, Zehetner J, DeMeester SR, Banki F, Lipham JC, DeMeester TR. An Improved Method of Assessing Esophageal Emptying Using the Timed Barium Study Following Surgical Myotomy for Achalasia. J Gastrointest Surg 2009;13:14-18. |
| 2,3 | Ayazi S, Lipham JC, Hagen JA, Tang AL, Zehetner J, Leers JM, Oezcelik A, Abate E, Banki F, DeMeester SR, DeMeester TR. A New Technique for Measurement of Pharyngeal pH: Normal Values and Discriminating pH Threshold. J Gastrointest Surg 2009;13:1422-1429. |
| 2,3 | Ayazi S, Hagen JA, Chan LS, DeMeester SR, Lin MW, Ayazi A, Leers JM, Oezcelik A, Banki F, Lipham JC, DeMeester TR, Crookes PF. Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux Symptoms. J Gastrointest Surg 2009;13:1440-1447. |
| 2,3 | Ling F, Hoelscher A, Vallbohmer D, Schmidt D, Picker S, Gathof B, Bollschweiler E, Schneider P. Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer. J Gastrointest Surg 2009;13:581-6. |
| 2,3 | Schröder W, Wirths K, Gutschow C, Vallbohmer D, Bludau M, Schumacher B, Neuhaus H, Hölscher A. Transthoracic Esophagectomy After Endoscopic Mucosal Resection in Patients with Early Esophageal Carcinoma J Gastrointest Surg, 2009; . |
| 2,2 | Hoffmann A, Vallbohmer D, Prenzel K, Metzger R, Heitmann M, Neiss S, Ling F, Holscher A, Schneider P, Brabender J. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. J Cancer Res Clin Oncol 2009;135:1231-7. |
| 2,1 | Alakus H, Monig SP, Warnecke-Eberz U, Alakus G, Winde G, Drebber U, Schmitz KJ, Schmid KW, Riemann K, Siffert W, Bollschweiler E, Holscher AH, Metzger R. Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer. World J Gastroenterol 2009;15:6061-7. |
| 2,1 | Kasper HU, Drebber U, Stippel DL, Dienes HP, Gillessen A. Liver tumor infiltrating lymphocytes: Comparison of hepatocellular and cholangiolar carcinoma. W J Gastroenterol 2009;15:5053-5057. |
| 1,9 | Markert E, Siebolts U, Habbig S, Odenthal M, Dienes H, Stippel D, Hoppe B, Wickenhauser C. Evolution of PTLD following renal transplantation in a child. Pediatr Transplant 2009;13:379-83. |
| 1,8 | Schmitz K, Müller CI, Reis H, Alakus H, Winde G, Baba HA, Wohlschläger J, Jasani B, Fandrey J, Schmid K. Combined Analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma. Int J Colorectal Dis 2009;24:1287-1296. |
| 1,6 | Hölscher AH, Vallböhmer D, Gutschow C, Bollschweiler E. Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure? Langenbecks Arch Surg 2009;394:417-24. |
| 1,6 | Stippel D, Bangard C, Prenzel K, Yavuzyasar S, Fischer J, Holscher A. Which parameters are needed for targeting a multitined radiofrequency device-an approach to a simple algorithm. Langenbecks Arch Surg 2009;394:617-22. |
| 1,6 | Wahba R, Bangard C, Kleinert R, Rosgen S, Fischer JH, Lackner KJ, Holscher AH, Stippel DL. Electro-physiological parameters of hepatic radiofrequency ablation-a comparison of an in vitro versus an in vivo porcine liver model. Langenbecks Arch Surg 2009;394:503-9. |
| 1,5 | Arnold D, Rummeny EJ, Kirchner T, Ridwelski K, Oettle H, Hartmann JT, Moehler M, Holscher A, Lang H, Schlitt HJ, Neuhaus P. Diagnosis and Treatment of Liver Metastases from Primary Colorectal Tumour. Onkologie 2009;33:7-12. |
| 1,4 | Riemann K, Struwe H, Alakus H, Obermaier B, Schmitz K, Schmid K, Siffert W. Association of GNB4 Intron-1 Haplotypes with Survival in Patients with UICC Stage III and IV Colorectal Carcinoma. Anticancer Res 2009;29:1271-4. |
| 1,4 | Grimminger P, Ling FC, Neiss S, Vallböhmer D, Lurje G, Schneider PM, Hölscher AH, Metzger R, Brabender J. The Role of the Homeobox Genes BFT and CDX2 in the Pathogenesis of Non-small Cell Lung Cancer. Anticancer Res. 2009 Apr;29(4):1281-6. |
| 1,4 | Grimminger P, Vallbohmer D, Bludau M, Brabender J, Metzger R, Holscher A. Successful management of esophageal perforation due to an aortic arch aneurysm replacement. Dis Esophagus 2009;22:471-4. |
| 1,4 | Metzger R, Vallbohmer D, Muller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hölscher AH, Schneider PM. Increased Human Telomerase Reverse Transcriptase (hTERT) mRNA Expression but not Telomerase Activity is Related to Survival in Curatively Resected Non-small Cell Lung Cancer. Anticancer Research 2009;29:1157-1162. |
| 1,4 | Leers JM, DeMeester SR, Ayazi S, Tang AL, Peyre CG, Lipham JC, Hagen JA, DeMeester TR. Recurrence of intramucosal esophageal adeno-carcinoma arising in a former esophagostomy site: a unique case report. Dis Esophag 2009;22:E17-E20. |
| 1,4 | Ling FC, Khochfar J, Baldus SE, Brabender J, Drebber U, Bollschweiler E, Hoelscher AH, Schneider PM. HIF-1alpha protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia. Dis Esophagus 2009;22:694-9. |
| 1,4 | Warnecke-Eberz U, Bollschweiler E, Drebber U, Metzger R, Baldus SE, Holscher AH, Monig S. Prognostic Impact of Protein Overexpression of the Proto-oncogene PIM-1 in Gastric Cancer. Anticancer Res 2009;29:4451-5. |
| 1,3 | Kasper HU, Ligum D, Cucus J, Stippel DL, Dienes HP, Drebber U. Liver distribution of gamma delta-T-cells in patients with chronic hepatitis of different etiology. Apmis 2009;117:779-785. |
| 1,0 | Langenbach, M., Stippel, A., Stippel, D.: Kidney Donors’ quality of life and subjective evaluation at 2 years after donation. Transplantat Proc 41, 2512 (2009) |
| 0,6 | Saeger HD, Kersting S, Vogelbach P, Hamel C, Oertli D, Holscher A, Thomas WE. Course system of the Working Group for Gastro-intestinal Surgery Davos. Chirurg 2009. |
| 0,6 | Semrau R, Vallbohmer D, Holscher A, Muller R. Neoadjuvant therapy of adenocarcinomas of the upper gastrointestinal tract. Status of radiotherapy. Chirurg 2009;80:1035-41. |
| 0,5 | Bollschweiler E. Breckheimer S, Mönig SP, Hölscher AH Einfluss von Alter und Begleiterkrankungen auf die Prognose von Patienten mit operiertem Magenkarzinom Zentralbl Chir 2009;134(1):71-6 |
| 0,5 | Grundmann R, Holscher A, Bembenek A, Bollschweiler E, Drognitz O, Feuerbach S, Gastinger I, Hermanek P, Hopt U, Hunerbein M, Illerhaus G, Junginger T, Kraus M, Meining A, Merkel S, Meyer H, Monig S, Piso P, Roder J, Rodel C, Tannapfel A, Wittekind C, Woeste G. Diagnosis of and therapy for gastric cancer--work-flow. Zentralbl Chir 2009;134:362-74. |
| - | Hölscher AH, Vallböhmer D, Bollschweiler E, Mönig SP. Magen- und Ösophagustumoren. Postoperative Sterblichkeit heute deutlich niedriger. MMW-Fortschr. Med 2009; 29-32. |
Publikationen 2008 sortiert nach der Höhe des Impact-Faktors 2007
| IF | IF Publikation: Autoren - Titel - Zeitschrift |
| 7,7 | Press OA, Zhang W, Gordon MA, Yang DY, Lurje G, Lqbal S, El-Khoueiry A, Lenz HJ. Gender-related survival differences associated with EGFR Polymorphisms in metastatic colon cancer. Cancer Research 2008;68:3037-3042. |
| 7,4 | Bollschweiler E, Apitsch J, Obliers R, Koerfer A, Mönig SP, Metzger R, Hölscher AH. Improving Informed Consent of Surgical Patients Using a Multimedia-Based Program? Results of a Prospective Randomized Multicenter Study of Patients Before Cholecystectomy. Ann Surg 2008; 248: 205-211. |
| 7,4 | Peyre CG, Hagen JA, ... Hölscher AH, .., DeMeester TR. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 2008; 248(4):549-56. |
| 7,4 | Peyre CG, Hagen JA, ... Hölscher AH, .., DeMeester TR. Predicting Systemic Disease in Patients With Esophageal Cancer After Esophagectomy - A Multinational Study on the Significance of the Number of Involved Lymph Nodes Ann Surg 2008; 248(6):979-85. |
| 7,4 | Schneider PM, Metzger R, Schaefer H, Baumgarten F, Vallbohmer D, Brabender J, Wolfgarten E, Bollschweiler E, Baldus SP, Dienes HP, Hoelscher AH. Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer Ann Surg 2008; 248(6):902-908. |
| 7,4 | Hölscher A.H. Laparoscopic Ischemic Conditioning of the Stomach for Esophageal Replacement. Ann Surg 2008; 247: 398. |
| 6,3 | Schultheis A, Lurje G, Rhodes K, Zhang W, Yang D, Garcia A, Morgan R, ... Fleming G, Roman L, Lenz H. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res 2008;14:7554-63. |
| 5,8 | Lurje G, Zhang W, Yang D, Groshen S, Hendifar AE, Husain H, Nagashima F, Chang HM, Fazzone W, Ladner RD, Pohl A, Ning Y, Iqbal S, El-Khoueiry A, Lenz HJ. Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer. Pharmacogenet Genomics. 2008 Feb;18(2):161-8. |
| 5,7 | Hoffmann AC, Mori R, Vallböhmer D, Brabender J, Klein E, Drebber U, Baldus SE, Cooc J, Azuma M, Metzger R, Hölscher AH, Danenberg KD, Prenzel KL, Danenberg PV. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF and bFGF. Neoplasia. 2008 Jul;10(7):674-9. |
| 5,3 | Quasdorff M, Hosel M, Odenthal M, Zedler U, Bohne F, Gripon P, Dienes H, Drebber U, Stippel D, Goeser T, Protzer U. A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation, Cell Microbiol 2008; 10(7):1478-90. |
| 4,9 | Lurje G, Zhang W, Schultheis A, Yang D, Groshen S, Hendifar A, ... Chang H, Lenz H. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol 2008;19:1734-41. |
| 4,6 | Harder J, Opitz OG, Brabender J, Olschewski M, Blum HE, Nomoto S, Usadel H. Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver. International Journal of Cancer 2008;122:2800-2804. |
| 4,1 | Bollschweiler E, Hölscher A. Prediction of tumour response by FDG-PET in patients with adenocarcinomas of the oesophagogastric junction. Eur J Nucl Med Mol Imaging 2008; 35:1742-1743. |
| 3,4 | Vallböhmer D, Kuhn E, Warnecke-Eberz U, Brabender J, Hoffmann AC, Metzger R, Baldus SE, Drebber U, Hoelscher AH, Schneider PM. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer. Pharmacogenomics 2008; 9:681-690 |
| 2,3 | Brabender J, Vallbohmer D, Grimminger P, Hoffmann A, Ling F, Lurje G, Bollschweiler E, Schneider P, Holscher A, Metzger R. ERCC1 RNA Expression in Peripheral Blood Predicts Minor Histopathological Response to Neoadjuvant Radio-chemotherapy in Patients with Locally Advanced Cancer of the Esophagus. J Gastrointest Surg 2008;12:1815-1821. |
| 2,3 | Hoffmann AC, Mori R, Vallbohmer D, Brabender J, Drebber U, Baidus SE, Azuma M, Metzger R, Hoffmann C, Holscher AH, Danenberg KD, Prenzel KL, Danenberg PV. High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIFla to HB-EGF and bFGF. J Gastrointest Surg 2008;12:1674-81. |
| 2,3 | Schröder W, Vallböhmer D, Bludau M, Banczyk A, Gutschow C, Hölscher A. The Resection of the Azygos Vein - Necessary or Redundant Extension of Transthoracic Esophagectomy?, J Gastrointest Surg, 2008;12(7), 1163-7. |
| 2,3 | Schröder W, Hölscher A.H. Response- The Resection of the Azygos Vein - Necessary or Redundant Extension of Transthoracic Esophagectomy? J Gastrointest Surg, 2008;12(12), 2248. |
| 2,3 | Warnecke-Eberz U, Prenzel K, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hölscher AH, Schneider PM. Significant Down-Regulation of the Plasminogen Activator Inhibitor 1 mRNA in Pancreatic Cancer Pancreas, 2008; 36: 173-177. |
| 2,2 | Bangard C, Stippel DL, Berg F, Kasper HU, Hellmich M, Fischer JH, Hölscher AH, Lackner K, Gossmann A. Conspicuity of zones of ablation after radio-frequency ablation in porcine livers: Comparison of an extracellular and an SPIO contrast agent J. Magn. Reson. Imaging 2008;28:263–270. |
| 2,0 | H. Alakus, G. Grass, J.K. Hennecken, E. Bollschweiler, C. Schulte, U. Drebber, S.E. Baldus, R. Metzger, A.H. Hölscher and S.P. Mönig Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer Histol Histopath 2008; 23:917-923 |
| 1,8 | Schaefer N, Schafer H, Maintz D, Wagner M, Overhaus M, Hoelscher A, Turler A. Efficacy of direct electrical current therapy and laser-induced interstitial thermotherapy in local treatment of hepatic colorectal metastases: an experimental model in the rat. J Surg Res 2008;146:230-40. |
| 1,8 | Schleimer K, Stippel D, Kasper H, Prenzel K, Gaudig C, Tawadros S, Hoelscher A, Beckurts K. Portal vein arterialization increases hepatocellular apoptosis and inhibits liver regeneration. J Surg Res 2008;149:250-8. |
| 1,7 | Reuter H, Gronke S, Adam C, Ribati M, Brabender J, Zobel C, Frank KF, Wippermann J, Schwinger RHG, Brixius K, Muller-Ehmsen J. Sarcoplasmic Ca2+ release is prolonged in nonfailing myocardium of diabetic patients. Molecular and Cellular Biochemistry 2008;308:141-149. |
| 1,6 | Drebber U, Baldus S, Nolden B, Grass G, Bollschweiler E, Dienes H, Holscher A, Mönig S. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. Oncol Rep 2008;19:1477-83 |
| 1,6 | Vallbohmer D, Marcus H, Baldus S, Brabender J, Drebber U, Metzger R, Holscher A, Schneider P. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors. Oncol Rep 2008;20:779-83. |
| 1,6 | Warnecke-Eberz U, Bollschweiler E, Drebber U, Pohl A, Baldus S, Hoelscher A, Metzger R. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases. Oncol Rep 2008;20:619-24 |
| 1,5 | Markert E, Siebolts U, Habbig S, Odenthal M, Dienes H, Stippel D, Hoppe B, Wickenhauser C. Evolution of PTLD following renal transplantation in a child. Pediatr Transplant 2009;13:379-83. |
| 1,4 | Vallbohmer D, Marcus HE, Baldus SE, Brabender J, Lurje G, Drebber U, Metzger R, Holscher AH, Schneider PM. Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors. Anticancer Research 2008;28:367-372. |
| 1,4 | Warnecke-Eberz U, Baldus SE, Bollschweiler E, Hoelscher AH, Metzger R. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis. Anticancer Research 2008;28:1525-1529. |
| 1,3 | Gutschow C, Bludau M, Vallbohmer D, Schroder W, Bollschweiler E, Holscher A. NERD, GERD, and Barrett's Esophagus: Role of Acid and Non-acid Reflux Revisited with Combined pH-Impedance Monitoring. Dig Dis Sci 2008;53:3076-81 |
| 1,3 | Neumann M, Wirtz M, Bollschweiler E, Warm M, Wolf J, Pfaff H. Psychometric Evaluation of the German Version of the "Consultation and Relational Empathy" (CARE) Measure at the Example of Cancer Patients. Psychother Psychosom Med Psychol 2008;58:5-15. |
| 1,2 | Pohl A, Zhang W, Ning Y, Manegold P, Lurje G, Lenz H. Targeting metastatic colorectal cancer in 2008: a long way from 5-FU. Oncology (Williston Park) 2008;22:456-62; discussion 462-3, 467-8, 474 passim. |
| 1,2 | Weihrauch M, Stippel D, Fries J, Arnold D, Bovenschulte H, Coutelle O, Hacker U. Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatment. Onkologie 2008;31:464-7. |
| 1,1 | Bollschweiler E, Knoppe K, Wolfgarten E, Hölscher A. Prevalence of Dysphagia in Patients with Gastroesophageal Reflux in Germany, Dysphagia 2008; 23: 172-176. |
| 1,1 | Bludau M, Vallbohmer D, Gutschow C, Holscher A, Schroder W. Quantitative measurement of gastric mucosal microcirculation using a combined laser Doppler flowmeter and spectrophotometer. Dis Esophagus 2008;21:668-672. |
| 1,1 | Gutschow C, Vallbohmer D, Stolte M, Oh D, Danenberg K, Danenberg P, Schneider P, Holscher A. Adenocarcinoma developing in de novo Barrett's mucosa in the remnant esophagus after esophagectomy: clinical and molecular assessment. Dis Esophagus 2008;21:E6-8. |
| 1,1 | Vallbohmer D, Holscher A, Brabender J, Prenzel K, Gutschow C, Schroder W, Metzger R, Bollschweiler E. Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma: is there really a difference? Dis Esophagus 2008;21:596-600. |
| 1,0 | Kaiser G, Sotiropoulos G, Jauch K, .... Holscher A, Rogiers X, Stangl M, Paul A, Broelsch C, Lang H. Liver transplantation for hilar cholangiocarcinoma: a german survey. Transplant Proc 2008;40:3191-3. |
| 1,0 | Schleimer K, Stippel D, Kasper H, Allwissner R, Yavuzyasar S, Holscher A, Beckurts K. Competition between native liver and graft in auxiliary liver transplantation in a rat model. Transplant Proc 2008;40:967-70. |
| 0,3 | Grundmann RT, Hermanek P, Merkel S,... Stippel D Diagnostik und Therapie von Lebermetastasen kolorektaler Karzinome - Workflow Zentralbl Chir 2008; 133:267-284 |
| 0,3 | Vivaldi C, Vallböhmer D, Hölscher M, Hölscher AH. Accidentally Swallowed Dentures - What is the Correct Diagnostic and Therapeutic Management? Zentralbl Chir 2008;133:82-85. |
| 0,1 | Bollschweiler E, Metzger R, Vallböhmer D, Hölscher AH. Mindestmengen in der Viszeralchirurgie- Was ist entscheidend: das Zentrum oder der einzelne Operateur? Chirurgische Gastroenterologie 2008 |
| 0,1 | Ell C, Hölscher AH. Esophageal cancer - Something is happening! Chirurgische Gastroenterologie 2008;24:8-8. |
| 0,1 | Heidecke CD, Hölscher AH, Rosch T, Stein HJ, Teichmann W, Wullstein C. Esophageal carcinoma. Chirurgische Gastroenterologie 2008;24:40-44. |
| - | Stippel DL Radiofrequenzablation maligner Leberläsionen. Indikation, Technik, Ergebnisse. chir praxis 2008; 68: 603-614. |
| - | Pohl A, Lurje G, Kahn M, Lenz HJ. Stem cells in colon cancer. Clinical Colorectal Cancer 2008;7:92-98. |
Publikationen 2007 sortiert nach der Höhe des Impact-Faktors 2006
